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1 Introduction
Hemodynamic monitoring is essential to provide optimal 
hemodynamic management to patients in perioperative and 
intensive care medicine. The Journal of Clinical Monitoring 
and Computing (JCMC) welcomes research articles investi-
gating hemodynamic monitoring technologies, cardiovascu-
lar pathophysiology, and hemodynamic treatment strategies 
that help advance this research field and eventually improve 
patient care. In this review, we highlight and summarize 
selected papers on hemodynamic monitoring and manage-
ment published in the JCMC in 2019.
2  Blood pressure monitoring
In a prospective study, Nicklas et al. [1] compared a non-
invasive continuous blood pressure monitoring system using 
the vascular unloading technique (CNAP system; CNSys-
tems Medizintechnik AG, Graz, Austria) with standard 
intermittent oscillometric upper arm cuff blood pressure 
measurements with regard to the ability to detect hypoten-
sive phases during complex gastrointestinal endoscopy. In 90 
patients, the continuous blood pressure signal of the CNAP 
system was compared to intermittent oscillometric blood 
pressure set at five-minute intervals. The authors defined a 
hypotensive phase as a time period of ≥ 30 s with ≥ 50% of 
the CNAP blood pressure measurements at least 10% below 
the last oscillometric measurement with either concurrent 
mean arterial pressure (MAP) ≤ 65 mmHg or systolic arterial 
pressure (SAP) ≤ 90 mmHg. Twenty-six patients (29%) had 
hypotensive phases with low MAP and 30% with low SAP. 
Overall, continuous blood pressure monitoring using the 
vascular unloading technique was able to detect hypotensive 
phases earlier compared to intermittent oscillometric blood 
pressure measurements and also identified short hypotensive 
phases that would remain undetected between intermittent 
oscillometric measurements. The authors conclude that con-
tinuous non-invasive blood pressure measurement can help 
to detect intraoperative hypotension more rapidly and has 
therefore the potential to improve patient safety.
An observational cohort study in cardiac surgery patients 
was performed by Henriques et al. [2] to investigate the 
relationship between the complexity of preoperative blood 
pressure and pulse pressure (PP) and preoperative risk 
prediction using the Society of Thoracic Surgeons (STS) 
Risk of Mortality and Morbidity Index and the European 
System for Cardiac Operative Risk Evaluation Score II 
(EuroSCORE II). The complexity of blood pressure and PP 
was quantified using multiscaled entropy from time series 
extracted from the blood pressure waveforms. Additionally, 
time series measures, mean, and standard deviation (SD) 
were calculated. Data sets of 147 patients were included in 
the final analysis. The EuroSCORE II was calculated in all 
147 patients, while the STS Mortality and Morbidity Index 
was only available in 115 patients (78%) having coronary 
artery bypass graft, aortic, or mitral valve surgery. Spearman 
correlation and linear regression were used to evaluate the 
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relationship between blood pressure complexity and the risk 
indices. The results showed an inverse relationship between 
blood pressure complexity and the STS Morbidity and Mor-
tality Index and EuroSCORE II. A one SD change in blood 
pressure complexity was associated with an increased risk 
for adverse outcome after cardiovascular surgery deter-
mined by either score. The results were consistent in a model 
adjusted for age, gender, and SD of the blood pressure time 
series. There are several limitations to this study, including 
that preoperative blood pressure measurements are only a 
rough estimate of normal baseline blood pressure [3], espe-
cially after premedication with midazolam. However, the 
results underline the importance of cardiovascular assess-
ment before major surgery.
There is a risk of measurements artifacts in large data sets 
as measurements are saved electronically without control-
ling. A growing number of hospitals use electronic records 
in perioperative and intensive care medicine. Therefore, Du 
et al. [4] developed a new algorithm to identify measure-
ment artifacts in automated records of perioperative blood 
pressure measurements. A total of 41,384 minute-by-minute 
blood pressure measurements of 54 anesthesia cases were 
analyzed and used to validate the developed algorithm 
against manual artifact identification. An error checking 
algorithm was applied to all blood pressure readings (SAP, 
diastolic, and MAP) to identify irregular recordings and sub-
sequently replace them with linear interpolation of neigh-
bors. Manual identification marked 509 blood pressure read-
ings as artifactual, of which 443 were also identified by the 
new algorithm resulting in a sensitivity of 87.0%. The cal-
culated specificity for the algorithm was 99.4%, as it marked 
256 pressure readings as artifactual, which were marked as 
regular in manual analysis. In the original data set, 8.8% of 
the intraoperative MAP measurements were > 100 mmHg 
and 4.3% were < 55 mmHg. After automated and manual 
correction 7.3% (automated) or 7.3% (manual) of MAP 
measurements were > 100 mmHg and 2.0% (automated) or 
2.1% (manual) were < 55 mmHg. The authors discuss poten-
tial limitations of the proposed algorithm during episodes 
with high blood pressure variability as it may be difficult 
to distinguish real variation from artifacts. Overall, artifact 
identification is an important issue and further development 
of error-checking algorithms may provide important support 
with data processing for researchers as well as clinicians 
using electronic medical records.
In a retrospective analysis, Harrison et al. [5] used the 
SaferSleep database with data from 55,896 pediatric anes-
thesia cases to report SAP alterations during cardiac and 
non-cardiac surgery. The authors included 2273 cases with 
intra-arterial blood pressure measurements and analyzed 
changes in intraoperative SAP in four different age groups. 
The patients were divided into the age-groups 1 to 30 days, 
1 month to 1 year, 1 year to 5 years, and 5 to 6 years, and 
included all American Society of Anesthesiologists physical 
status classifications. The SAP changes were assessed over 
two measurement intervals, 30 s and 300 s, and analyzed 
using normalization and principal component analysis. The 
mean (SD) SAP in age-group 1 to 30 days old was 55.7 
(16.7) mmHg during cardiac surgery and 55.2 (17.6) mmHg 
during non-cardiac surgery. Age-group 1 month to 1 year 
had a mean SAP of 64.8 (23.2) mmHg during unspecified 
cardiac surgery and 70.6 (21.6) mmHg during non-cardiac 
surgery. The mean SAP in patients 1 year to 5 years old was 
68.6 (23.5) mmHg during cardiac surgery and 80.1 (18.8) 
mmHg during non-cardiac surgery. In the age-group with 
5 to 6 years, the mean SAP was 71.8 (24.8) mmHg during 
cardiac surgery and 85.4 (17.7) mmHg during non-cardiac 
surgery. The average changes in SAP over 30 s and 300 s 
were similar across all groups and both cardiac and non-
cardiac cases. The presented data do not distinguish between 
different methods for general anesthesia, and only SAP 
was included. Additionally, the age-group 1 to 5 years old 
included a heterogeneous group of pediatric patients. The 
authors concluded that further research on hemodynamic 
management of pediatric patients is necessary to provide 
a better understanding of their cardiovascular physiology 
and the response to general anesthesia. This is an important 
research topic and the current study provides interesting 
information on the variation of blood pressure in different 
age-groups.
3  Blood flow monitoring
In 2019, five papers on cardiac output monitoring were pub-
lished in the JCMC.
Vetrugno et al. [6] compared transpulmonary thermodi-
lution cardiac output (VolumeView/EV1000/Hemosphere; 
Edwards Lifesciences, Irvine, CA, USA) to pulmonary 
artery thermodilution cardiac output (pulmonary artery 
catheter and Vigilance/Hemosphere monitor; Edwards Lifes-
ciences) in 49 patients undergoing liver transplant surgery. 
The percentage error ranged from 29% to 43% depending on 
the stage of surgery, data being least in agreement during the 
anhepatic and reperfusion stages. Trending ability was poor 
even within the defined stages of surgery. One would have 
expected better agreements and the authors’ conclusions did 
not reflect the wide variations in readings between the two 
methods, especially during the anhepatic and reperfusion 
stages. Based on these findings, the use of the VolumeView/
EV 1000/Hemosphere system during liver transplantation 
surgery could not be recommended.
Also using the Volume View/EV 1000/Hemosphere sys-
tem, Nakwan et al. [7] investigated the validity of two car-
diac contractility indices derived from the transpulmonary 
thermodilution curve, (i) cardiac function index (CFI) and 
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(ii) global ejection fraction (GEF). Transthoracic echocar-
diography was used as reference method, measuring left 
ventricular ejection fraction. Thirty-two ventilated septic 
shock patients were included and receiver operating charac-
teristics (ROC) curves were used to calculate the predictive 
ability of the CFI and GEF for the left ventricular ejection 
fraction. The results showed an area under the ROC curve 
(AUC ROC) for the CFI to predict a left ventricular ejection 
fraction ≥ 40% (AUC ROC: 0.926), ≥ 50% (AUC ROC: 0.924), 
and ≥ 60% (AUC ROC: 0.875). Similar results were found for 
the predictive ability of the GEF (left ventricular ejection 
fraction ≥ 40% (AUC ROC: 0.934), ≥ 50% (AUC ROC: 0.938), 
and ≥ 60% (AUC ROC: 0.887). Further studies were recom-
mended to confirm these findings.
Maeda et  al. [8] compared cardiac output values 
obtained with the fourth generation FloTrac/Vigileo soft-
ware (Edwards Lifesciences) to pulmonary artery catheter 
thermodilution-derived readings. Cardiac output by the Fick 
Method using the E-CAiOV (GE Healthcare, Chicago, IL, 
USA) was also included in the study. Data were collected 
from 22 cardiac surgery patients at six time points. Systemic 
vascular resistance was increased by administering phenyle-
phrine. The data comparisons were notable because of the 
appalling percentage errors of over 70% for the Fick Method 
with the E-CAiOV, though percentage error did improve 
to < 30% for the FloTrac when cardiac output was high.
One of the more recently marketed technologies to meas-
ure cardiac output is the BSM-9101 bedside monitor (Nihon 
Kohden, Tokyo, Japan). It provides estimated continuous 
cardiac output (esCCO) based on pulse wave transit time 
technology measured using the electrocardiogram (ECG) 
and peripheral pulse oximeter. Suzuki et al. [9] compared 
both cardiac output and stroke volume variation (SVV) 
against FloTrac readings in 21 post cardiovascular surgery 
patients, mainly aortic aneurysm repairs. The data did not 
support the clinical use of esCCO as percentage errors were 
69% and 99% for cardiac output and SVV, respectively. 
However, arterial pulse contour analysis is not an established 
reference method in cardiac output validation studies. Fur-
thermore, choosing a patient cohort with significant arterial 
disease further challenges the reliability of the pulse contour 
method. Despite the authors’ optimism about their results, 
one has to question the soundness of the study design.
Tantot et al. [10] studied the monitoring potential of an 
index derived from the ratio of real-time PP over MAP (PP/
MAP). The index was used intra-operatively to guide fluid 
or vasopressor administration. One hundred and three neu-
rosurgery patients were studied. The rationale was the simi-
larity of PP/MAP to the Liljestrand–Zander equation which 
is used to transform the arterial pressure wave into blood 
flow measurements. This equation has been shown to track 
vasopressor induced changes in cardiac output in several 
studies. Oesophageal Doppler (i.e. CardioQ, Deltex Medical, 
Chichester, UK) was used as the reference method. The best 
correlation between variation in PP/MAP and changes in 
cardiac output was found after phenylephrine (r = 0.53, 
p < 0.001) and norepinephrine (r = 0.41, p < 0.001). How-
ever, the results after ephedrine infusion or fluid administra-
tion showed no correlation. The authors’ overall conclusion 
was that monitoring PP/MAP would be difficult to apply in 
current clinical practice.
4  Cardiovascular physiology
Arterial stiffness is a prognostic variable for cardiovascular 
morbidity and mortality [11]. Changes in arterial stiffness 
can be assessed by measuring the changes in pulse wave 
velocity (PWV). Two systems which are generally used in 
clinical practice to measure PWV are Biopac (Biopac Sys-
tems Inc, Goleta, CA, USA) which uses a photoplethysmog-
raphy sensor placed on the fingertip combined with ECG 
leads, and Complior (Alam Medical, Vincennes, France) 
which uses piezoelectric sensors placed on the skin over the 
carotid and radial arteries. In the April issue, Van Velzen 
et al. [12] compared these two systems in healthy volun-
teers, which were subjected to various positional changes, 
and found that the Biopac system measured consistently and 
significantly lower PWV values compared to the Complior 
system. In seated healthy volunteers, the Biopac system 
measured a PWV of 3.0 ± 0.2 m/s compared to a PWV of 
10.2 ± 1.4 m/s for the Complior system. The Biopac system 
measures a more peripheral trajectory with the vessels of the 
finger being included. More peripheral vessels are narrower 
and possibly more compliant, which likely reduces PWV. 
The authors discuss that these factors may outweigh the 
reduced radius of the peripheral vessels, which potentially 
increases PWV. The correlation coefficient between the 
PWV values of the two systems and Bland–Altman analysis 
of the measured PWV values showed that there was a fair 
agreement between the two methods. The authors conclude 
that both systems can be used to measure changes in PWV as 
long as the difference in magnitude between the systems is 
taken into account. Clinicians wanting to measure a singular 
PWV for diagnosis and prognosis should be aware that the 
absolute PWV values may differ considerably based on the 
method used.
Capillary refill time (CRT) is the time for skin color to 
fully return after applying firm pressure at the index finger. 
CRT is part of the clinical examination of the critically ill 
patient suspected of circulatory shock as it is a variable of 
peripheral tissue perfusion. However, there may be inter-
observer variability for the measurement of CRT as it is a 
subjective assessment. Optical infrared spectroscopy can be 
used to objectively measure peripheral tissue perfusion (this 
is referred to as blood refill time (BRT) to distinguish the 
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two methods). Optically measured BRT rather than visually 
assessed CRT allows for a high fidelity mechanical measure-
ment of peripheral blood perfusion. At the moment, there is 
uncertainty regarding the potential interference of tempera-
ture and age on measurements of peripheral tissue perfu-
sion [13]. In the April issue, Shinozaki et al. [14] performed 
measurements of BRT in healthy volunteers during different 
temperature settings and found that a lower fingertip tem-
perature significantly increased BRT. A mechanical device 
was built to objectively measure BRT, which compresses 
and releases the fingertip in a standardized manner, and 
estimated changes in blood volume using infrared light. At 
room temperature, the volunteers’ fingertip temperature was 
32.1 ± 3.0 °C, with a BRT of 1.96 (95% confidence interval 
(CI) 1.60–2.33) seconds. When the volunteers’ hands were 
submerged in 15 °C water, the fingertip temperature was sig-
nificantly colder (23.6 ± 3.6 °C), with a significant increase 
in BRT to 4.67 (95% CI 3.57–5.76) seconds. Different age 
and race of the healthy volunteers were analyzed as pos-
sible confounders, but after adjusting for the temperature 
difference, the sample size proved to be too small to provide 
reliable conclusions. One of the findings of this article is that 
clinicians should be careful in the interpretation of bedside 
measurements of peripheral blood perfusion, as these are 
influenced by temperature.
Phenylephrine is an α1-adrenergic receptor agonist that 
is predominantly used to increase vascular tone, and thus 
increase cardiac afterload and blood pressure [15]. There 
is still uncertainty regarding the effects of phenylephrine 
on venous return, preload, and contractility. Wodack et al. 
[16] assessed the hemodynamic effects of phenylephrine 
in an animal study and found that phenylephrine increases 
effective preload and contractility besides its known vas-
cular properties. The authors investigated these effects in 
eight mechanically ventilated pigs, which were subjected 
to a step-wise increase in phenylephrine dosages. Hemo-
dynamic data were obtained after placing an arterial cath-
eter, central venous catheter, aortic and pulmonary artery 
flow probes, and a transpulmonary thermodilution moni-
tor (PiCCO2; Pulsion Medical Systems, Feldkirchen, 
Germany). The measured MAP was used to define base-
line MAP (M0; 62 ± 7 mmHg), and a MAP increase of 
50% (M1; 87 ± 5 mmHg) and 100% (M2; 112 ± 4 mmHg) 
were chosen to define the relevant time points. The preload 
enhancing effects of phenylephrine were demonstrated by 
an increase in global end-diastolic volume (GEDV): GEDV 
was 362 ± 51 mL at M0 and increased to 405 ± 72 mL at 
M1 and to 415 ± 58 mL at M2. The increased contractil-
ity with phenylephrine administration was demonstrated 
by an increase in CFI, GEF, and the aortic dPmx, which 
is a variable to estimate pressure changes during the sys-
tolic phase. CFI was 7.1 ± 1.1 L/min at M0 and increased to 
8.5 ± 1.1 L/min at M1, and to 9.7 ± 1.6 L/min at M2. GEF 
was 33.3 ± 5.7% at baseline and increased to 38.5 ± 3.5% 
at M1, but did not increase further at M2 (39.2 ± 4%). 
dPmx was 628 ± 285 mmHg/s at baseline and increased to 
1105 ± 535 mmHg/s at M1, and to 1607 ± 758 mmHg/s at 
M2. The authors conclude that phenylephrine may be inves-
tigated in clinical practice as measure to recruit preload and 
increase contractility.
The article discussed above was accompanied by an edi-
torial discussing the physiology involved in phenylephrine-
induced recruitable preload. In this editorial, Jacobs et al. 
[17] discuss the promising results shown in the animal study 
by Wodack et al. [16] and elaborate on the potential role of 
the early application of vasopressors to recruit blood from 
the venous compartment. The authors first revisit the con-
temporary standards of fluid resuscitation in patients with 
circulatory shock, which find their origin in the aggressive 
fluid treatment applied in patients with cholera almost 200 
years ago. We now know that care has to be taken to prevent 
excessive fluid administration, as this leads to edema and 
increased morbidity in critically ill patients [18]. Second, 
the cardiovascular physiology involved with the application 
of vasoconstriction to recruit preload is discussed. Further-
more, the results obtained in the animal study are revisited, 
and potential limitations of the study design are discussed. 
The authors of the editorial conclude that the early applica-
tion of vasopressors has promise, but more clinical studies 
are needed to evaluate how these management changes may 
affect patient outcomes.
The assessment of right ventricular dysfunction has 
gained increased interest in perioperative and intensive care 
as it is associated with mortality and organ dysfunction. Vis-
tisen et al. [19] performed a retrospective analysis with data 
from the Medical Information Mart for Intensive Care III 
database from Beth Israel Deaconess Medical Center [20] 
to investigate characteristics of the waveform of post-extra-
systolic beats in patients with right ventricular dysfunction 
and healthy controls. The authors identified 24 patients with 
right ventricular dysfunction and 34 control patients with 
available echocardiographic reports. The right ventricular 
function was analyzed in the 2nd and 3rd post-ectopic beat 
after ventricular extrasystoles. The mean reduction of the 
SAP at the 2nd and 3rd beat was lower in the group with 
right ventricular dysfunction compared to the control group 
with a mean (SD) of −1.7 (1.9)% vs. −3.6 (1.9)%. The AUC 
ROC for the identification of right ventricular dysfunction 
based on reduction in SAP was 0.76 with an optimal speci-
ficity of 91% and a corresponding sensitivity of 50%. Using 
maximization of the Youden index, the respective specificity 
was 71% with a sensitivity of 75% at a threshold of -2.85%. 
Even though extrasystoles and the analysis of concurrent 
hemodynamic changes may be of great interest for analysis 
of the cardiovascular system, they occur infrequently and are 
only observed in few patients. Therefore, monitoring devices 
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would have to detect extrasystoles and subsequent changes in 
SAP. The accompanying editorial by Pinsky [21] discusses 
the study by Vistisen et al. [19] in detail underlining the 
importance of right ventricular function and its assessment 
in critical care patients.
An experimental method comparison study with 12 York-
shire pigs was performed by Monge Garcia et al. [22] to 
evaluate the estimation of arterial elastance from different 
sites in comparison with arterial elastance measured with a 
left ventricular conductance catheter as reference method. 
The authors obtained arterial blood pressure measurements 
from aortic, femoral, and radial artery catheters. The calcula-
tion of arterial elastance was based on arterial pressure with 
arterial elastance based on 90% of SAP, MAP, and dicrotic 
notch pressure in relation to the stroke volume. During the 
study period, several maneuvers were performed to induce 
changes in afterload (phenylephrine and nitroprusside), 
preload (bleeding and fluid bolus), and contractility (esmolol 
and dobutamine). Bland–Altman analysis was performed to 
compare the agreement between the different estimates of 
arterial elastance. The overall results showed good correla-
tion between arterial elastance measurements obtained with 
the different arterial catheters (aortic, femoral, radial) and 
different methods (90% SAP, MAP, dicrotic notch) with the 
reference method (all  r2 > 0.92). The calculation of arterial 
elastance based on MAP (MAP/stroke volume) showed the 
lowest mean of the differences and narrow limits of agree-
ment. The authors support the use of MAP as a standard 
for the calculation of arterial elastance, since the measure-
ments were interchangeable between the different measure-
ment sites. With increased interest in arterial elastance as a 
measurement for arterial load this study provides interesting 
evidence for future research in this field.
An observational study in 15 cardiac surgery patients 
was performed by Tusman et al. [23] to evaluate, whether 
the photoplethysmography (PPG) signal can be used to 
detect changes in arterial blood pressure and vascular tone. 
The systemic vascular resistance and vascular compliance 
(stroke volume/PP) were used as surrogates for vascular 
tone. Based on the amplitude of the PPG signal (maxi-
mum to minimum) and the position of the dicrotic notch, 
seven classes of vascular tone were defined. A dicrotic 
notch between 20 and 50% of the amplitude was defined as 
normal vascular tone (Class III). A decreased PPG ampli-
tude and a dicrotic notch near the systolic peak (Class I) 
or in the upper 50% of the PPG waveform (Class II). An 
increased PPG amplitude and a dicrotic notch at 20% of the 
maximum of the PPG waveform (Class IV), at the foot of 
the PPG (Class V) or even a negative dicrotic notch (Class 
VI) were used to identify states with vasodilation. A total 
of 190 datasets with 61 hypertensive (vasoconstriction), 84 
normotensive, and 45 hypotensive (vasodilation) episodes 
were included in the final analysis. A Spearman rank test 
showed a correlation between the PPG based classification 
of vascular tone with SAP (r =  −0.90, p < 0.0001), systemic 
vascular resistance (r =  −0.72, p < 0.0001), and vascular 
compliance (r =  −0.77, p < 0.0001). The analysis of only 
the amplitude of the PPG signal showed a correlation with 
SAP (r =   −0.79, p < 0.0001), systemic vascular resistance 
(r = −0.66, p < 0.0001), and vascular compliance (r = 0.82, 
p < 0.0001) as well. Overall, a total of 183 out of 190 epi-
sodes were correctly identified as hypertensive, normoten-
sive, or hypotensive. The calculated sensitivity was 100% 
with a specificity of 97.9% for the detection of hypotension 
and 94.9% with a specificity of 99.2% for the detection of 
hypertension. The authors concluded that changes in arte-
rial blood pressure mediated by changes in vascular tone 
were closely connected to the shape of the PPG waveform. 
However, future studies will need to investigate the accuracy 
and applicability in a broader patient spectrum.
In another prospective observational study, Li et al. [24] 
used a porcine cardiac arrest model to investigate if the 
PPG waveform can identify the return of spontaneous cir-
culation (ROSC) during cardiopulmonary resuscitation. Six 
pigs received chest compressions without cardiac arrest and 
six pigs had three minutes of untreated ventricular fibrilla-
tion followed by two minutes with chest compressions and 
subsequent defibrillation. After ROSC, chest compressions 
were performed for another five minutes. ROSC was defined 
as a measurable pulse and blood pressure with an abrupt 
increase in end-tidal carbon dioxide (≥ 40 mmHg). Time and 
frequency domain methods were used to analyze the PPG 
waveform. At baseline both groups showed a single peak in 
the frequency domain method. In the group without cardiac 
arrest the results showed a stable heart rate, whereas dias-
tolic blood pressure increased and end-tidal carbon dioxide 
decreased during chest compressions compared to baseline. 
At the same time, the time domain method showed a hybrid 
fluctuation or “envelope” phenomenon with a “double” or 
“fusion” peak in the frequency domain method. Interest-
ingly, one of the peaks had a rate around 110 per minute 
matching the rate of chest compressions, while the second 
peak matched the “drifting” frequency of a spontaneous 
pulse in the group without cardiac arrest. In the group with 
ventricular fibrillation, the PPG waveform disappeared dur-
ing ventricular fibrillation, but returned after the initiation of 
chest compressions. After defibrillation, the PPG waveform 
showed a hybrid fluctuation or envelope phenomenon with 
double or fusion peak similar to the group without cardiac 
arrest. The authors state that these effects may be caused 
by chest compressions with simultaneous regular pulse and 
depend on the frequency deviation. Therefore, the authors 
argue that the existence of two peaks may be a characteristic 
of ROSC during cardiopulmonary resuscitation. However, 
future research is necessary to investigate the clinical appli-
cability of this method.
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5  Perioperative goal‑directed therapy
Perioperative goal-directed therapy (pGDT) is a widely 
adopted strategy for optimizing cardiovascular dynamics in 
perioperative medicine. pGDT has been shown to improve 
postoperative outcomes in patients having high-risk sur-
gery of different kinds and has been implemented in sev-
eral national and international guidelines. Nevertheless, its 
implementation into clinical practice is not widespread, and 
even in places where it is used, protocol adherence is ham-
pered by workload, cost issues related to additional moni-
toring, and skepticism of clinical staff. The consequence is 
a large inter- and even intra-provider variability in hemo-
dynamic management [25], resulting in varying outcomes 
[26]. This issue may be resolved by offering clinicians a 
real-time decision support helping them to decide when and 
how much volume and vasoactive agents should be given 
to optimize the patient’s hemodynamics. Joosten et al. [27] 
tested the feasibility of the commercially available “Assisted 
Fluid Management” (AFM) software (Edwards Lifesciences) 
to guide pGDT in 46 patients undergoing major abdominal 
surgery. The software was build based on algorithms previ-
ously created and validated by the same group of authors for 
developing a closed-loop fluid administration system. It is 
primarily based on SVV but also considers heart rate, MAP, 
and stroke volume, and is “learning” from the individual 
patient’s hemodynamic reaction on the successive fluid 
administrations. When the AFM software suggests giving a 
fluid bolus, this suggestion could be followed or not by the 
provider. If the fluid option was chosen, a button on the inter-
face screen was pushed so that the system could analyze the 
hemodynamic status before and after fluid administration. 
In the current study, the time spent below predefined targets 
of SVV as well as the fluid requirements of these patients 
was compared to those of a historical control group of 38 
patients receiving conventional pGDT with the same hemo-
dynamic targets. Maintenance infusion was low (2 mL/kg/h) 
in both groups, and 250 mL of crystalloids were supposed 
to be given when SVV >13% in the control group or when 
the AFM software suggested so in the intervention group. 
In addition, vasopressors were allowed to treat hypotension 
(defined as MAP < 65 mmHg) not related to hypovolemia, 
and colloids in case of major blood loss (> 1000 mL). The 
authors tested the hypothesis that AFM increased the time 
spent with a SVV < 13% as compared to pGDT (control). 
And indeed, patients in the AFM group spent more time 
below the target SVV than the historical control group 
(median 92% vs. 76%, p < 0.0005), despite receiving less 
fluid (1775 mL vs. 2350 mL, p = 0.01). The resulting less 
positive fluid balance (1010 mL vs. 1725 mL, p < 0.001), 
however, did not translate into improved patient outcomes, 
as postoperative complications were similar between groups. 
Yet, the length of stay in the intensive care unit (ICU) or 
post anesthesia care unit and in hospital were significantly 
shorter in the AFM group. The AFM software recommended 
5 fluid administrations on average per patient (range 0–18), 
i.e. about one per hour during surgery. A high proportion 
of the recommended fluid administrations (238/245; 97%) 
were followed by the clinicians, of which 52–65% lead to an 
increase in stroke volume of 15% and 10% or more, respec-
tively. Unfortunately, protocol compliance was not registered 
in the control group. The high compliance in the AFM group 
might be explained by the plausibility of the recommenda-
tions to give fluids, meeting the clinicians’ expectations, and 
the reduced workload.
In the accompanying editorial comment, van Beest [28] 
discussed the difficulties of implementing new strategies into 
clinical practice. Furthermore, he pointed out that although 
both AFM and the conventional pGDT algorithm were based 
on SVV in the Joosten study [27], actually the AFM algo-
rithm might have been more physiologically driven by learn-
ing from the individual reactions to previous fluid admin-
istrations. He was convinced that AFM might alleviate the 
implementation of pGDT protocols into clinical practice.
A different approach of guiding pGDT was chosen by 
Cesur et al. [29] in their prospective randomized study. The 
pleth variability index (PVI) is a non-invasively derived 
(from pulse oximetry) dynamic variable to predict fluid 
responsiveness based on heart–lung interactions [30] that 
has previously been used to guide pGDT [31]. Cesur et al. 
compared a PVI-guided pGDT (using a PVI threshold 
of > 13% to trigger a 250 mL colloid administration) with a 
conventional fluid management (CFM; based on blood pres-
sure, heart rate, central venous pressure (CVP) and urine 
output) in 70 patients having colorectal surgery. Of note, 
the maintenance fluid rates differed markedly (2 mL/kg/h in 
the pGDT group vs. 4–8 mL/kg/h in the CFM group). The 
primary endpoints were fluid requirements as well as lactate 
and creatinine levels. Fluid administration was significantly 
higher in the CFM group (1950 vs. 900 mL, p < 0.001), 
while fluid balance was significantly lower in the pGDT 
group (620 vs. 1400 mL, p < 0.001). Again, these differ-
ences did not translate into outcome differences besides a 
slightly shorter time to passage of stool in the pGDT group 
(4.5 vs. 5 days). The other endpoints, such as renal function 
and length of hospital stay, were also similar in both groups. 
This study confirms previous findings showing that dynamic 
variables were superior to static variables like CVP to guide 
fluid management, and that these dynamic variables can be 
derived non-invasively by pulse oximetry.
Besides hemodynamic monitoring, which is an integral 
component of pGDT, also depth-of-anesthesia (DoA) moni-
toring might contribute to the outcome of high-risk surgical 
patients. In a before-after study setup, Lima et al. [32] stud-
ied the effect of implementing guidelines for hemodynamic 
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and DoA monitoring in their hospital on intraoperative 
drug and fluid consumption and postoperative complica-
tions. They retrospectively included a large number of 
patients (n = 596) undergoing abdominal cancer surgery, 
313 of which were included before (before group) and 283 
after protocol implementation (after group) after having 
instructed their caregivers on the hemodynamic and DoA 
targets of their guidelines. While baseline characteristics and 
procedures were comparable between groups, postoperative 
morbidity (particularly delirium and urinary tract infections) 
was significantly lower and hospital length of stay shorter 
after guideline implementation. This was associated with 
an about 50% increase in the use of hemodynamic and DoA 
monitoring and a reduction in intraoperative fluid adminis-
tration. Interestingly, the adoption of the new monitoring 
guidelines varied across specific variables, with DoA moni-
toring being implemented in most patients (88%), cardiac 
output monitoring in 61% and central venous oxygen satu-
ration monitoring in only 29%. The authors speculated that 
invasiveness, costs, and unease of use may have hampered 
the use of hemodynamic monitoring in their study. The fact 
that they did find outcome benefits despite the low proto-
col implementation rate implies that the effects might have 
been even larger with a higher adoption of hemodynamic 
optimization.
The advantages and disadvantages of a before-after study 
design as opposed to the scientific standard of a randomized 
controlled trial were discussed in the accompanying edito-
rial comment by Saugel et al. [33]. While the question about 
the best study design to investigate a potentially beneficial 
impact of pGDT on patient outcome cannot be definitely 
answered, the editorial comes to the conclusion that both 
study designs have their place and value in contributing to 
find out if pGDT actually improves patient outcome in real-
life daily clinical practice.
6  Fluid responsiveness
Measuring dynamic fluid responsiveness variables nor-
mally requires advanced hemodynamic monitoring. The 
smartphone application Capstesia (Galenic App, Vitoria-
Gasteiz, Spain) is able to calculate pulse pressure varia-
tion (PPV) from a picture of the invasive arterial pressure 
waveform taken from any monitor screen without the need 
for additional hemodynamic monitoring systems or sensors. 
Joosten et al. [34] compared PPV obtained with Capstesia 
with SVV measured with uncalibrated pulse wave analysis 
in 40 patients with major abdominal surgery based on pre-
defined categories (PPV and SVV < 9%, 9–13%, and > 13%) 
reflecting decision thresholds to administer fluids. The 
overall agreement between PPV and SVV was 79% and the 
Kappa coefficient was 0.55. After the induction of general 
anesthesia but before surgical incision, an accuracy of 84% 
and a Kappa coefficient of 0.61 were observed. In only 1% of 
the cases, PPV and SVV would have resulted in completely 
opposite clinical decisions. The authors concluded that Cap-
stesia might be an easy and usable alternative to advanced 
monitoring technologies for the assessment of dynamic fluid 
responsiveness variables. Further studies are needed to con-
firm the potential and limits of this application.
Park et al. [35] investigated another method to predict 
fluid responsiveness in 38 pediatric patients having car-
diac or neurosurgical surgery using respiratory variations 
in the pulse oximetry plethysmography waveform (ΔPOP). 
Since it has been shown that the contacting force between 
the sensor and measurement site affects the signal quality, 
this study investigated the effect of different contacting force 
conditions on ΔPOP and the ability of the system to predict 
fluid responsiveness. The ability of ΔPOP to predict fluid 
responsiveness before a 10 mL/kg 6% Volulyte (Fresenius 
Kabi GmbH, Bad Homburg, Germany) infusion was signifi-
cantly different between fluid responders and non-responders 
at a contacting force of 0.9–1.2 N (AUC ROC: 0.815 [95% 
CI 0.674–0.956; p = 0.002]) and at individually adjusted 
contacting force (AUC ROC: 0.847 [95% CI 0.716–0.978; 
p < 0.000]). Since ΔPOP seems to be a reliable indicator to 
predict fluid responsiveness at a certain contacting force and 
is measured non-invasively and relatively easy, this study is 
an important contribution for this methodology.
Another interesting and clinically relevant study in 88 
patients with spinal surgery investigated the ability of 
PPV to predict fluid responsiveness in prone compared to 
supine patient position and studied the effects of body mass 
index, intra-abdominal pressure, and respiratory system 
compliance (CS) on PPV [36]. The authors measured PPV, 
intra-abdominal pressure, and CS in the supine position, 
after changing into the prone position, and after a fluid chal-
lenge of 500 mL isotonic saline in the prone position. The 
study revealed that PPV in the prone position was able to 
predict fluid responsiveness compared to PPV in the supine 
position if the patient’s body mass index was < 30 kg/m2 
and CS > 31 mL/cmH2O. Since the prone position is obliga-
tory for many surgical procedures and a treatment option in 
patients suffering from acute respiratory distress syndrome, 
this study provides clinically important insights for these 
indications.
Vistisen et al. [37] investigated the use of extrasystoles 
and micro-fluid challenges to predict fluid responsiveness 
as an alternative to PPV in two different time windows 
(after anesthesia induction and during bypass preparation) 
in 61 patients having elective coronary artery bypass graft 
surgery. In each time window, after an initial observation 
for extrasystoles, a micro-fluid challenge (50 mL in 10 s) 
was performed and thereafter a traditional fluid challenge 
(5 mL/kg). The study revealed insufficient validity of the 
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two investigated methods during cardiac surgery, which 
might have been caused by several factors (e.g., study set-
ting, patients’ demographic characteristics, premedication 
with beta-blockers) or simply a non-adequate predictive abil-
ity of the methods in these specific patients. Since dynamic 
variables such as PPV and SVV have several limitations 
(e.g., special ventilator settings, non-usability during open-
chest surgery) this study is an important contribution to find 
alternatives for predicting fluid responsiveness in patients 
with unreliable PPV measurements. However, new methods 
for predicting fluid responsiveness have to be investigated 
further, especially to define their area of application and 
limitations.
In a pilot study, Pybus [38] investigated the feasibility 
of performing real-time spectral analyses of the respira-
tory and arterial pressure waveform in 60 cardiac surgical 
patients and assessed the clinical utility of this technique to 
predict fluid responsiveness. For this purpose, he performed 
real-time calculation of the “spectral peak ratio” (SPeR) in 
patients undergoing aortic valve replacement during an 
increase of the tidal volume over 2 min and found a strong 
linear correlation between SPeR and tidal volume. The slope 
β of this relationship may be used to represent the slope 
of the cardiac response curve at its equilibrium point with 
the venous return curve in the “classical” Guyton model, 
and changed significantly after aortic valve replacement 
(1.58 ± 0.78 vs. 1.79 ± 0.8). Additionally, β fell significantly 
during a passive leg raising maneuver. Further studies are 
needed to evaluate this technique in detail and find its place 
in daily clinical practice.
Sun et al. [39] performed a prospective method compari-
son study to evaluate the agreement of the pulse amplitude 
variation assessed with PPG at the finger and on the forehead 
with PPV derived from an arterial blood pressure signal. A 
total of 29 patients having major vascular or urologic surgery 
were included in the study. Bland–Altman analysis showed a 
mean of the differences between finger derived pulse ampli-
tude variation and PPV of 3.2 ± 5.1%, which improved to 
1.2 ± 3.8% after baseline correction. The forehead-derived 
pulse amplitude variation had a larger difference of the 
means with 12.0 ± 9.1%, which decreased to 3.3 ± 4.8% 
after baseline correction. The results indicated no effect of 
other potential confounding factors like the heart rate to res-
piratory rate ratio, the perfusion index, and the PPV itself. 
Overall, the results indicated that pulse amplitude variation 
may serve as a non-invasive alternative to PPV. However, the 
PPG signal may be insufficient in critical care patients with 
shock or on high-dose vasopressor therapy as peripheral 
perfusion may be impaired. Additionally, pulse amplitude 
variation needs detailed analysis of the pulse wave and may 
not bet detected by eyeballing.
7  Artificial intelligence and machine 
learning
The number of published studies applying machine learning 
methods to clinical data is exploding these years, and for 
JCMC, 2019 was also mirroring this trend. Last year, we 
saw five original papers applying various types of machine 
learning techniques/algorithms to clinical data. All studies 
had a retrospective design and authors predominantly tried 
to predict hemodynamic events/derangements such as tachy-
cardia [40], hypotension [41] and cardiac arrest [42], but 
we also saw one before/after implementation study [43] and 
another study trying to identify patterns between clinical 
practice and outcomes advised by machine learning tech-
niques [44]. For one of the original papers [40], an accompa-
nying editorial was published highlighting important aspects 
of the reporting of such papers [45]. Finally, general and 
future aspects of applying machine learning to continuously 
monitored physiological data was highlighted in an excel-
lent narrative review [46], where Rush et al. stated in their 
introduction that “Machine learning is a term likely spoken 
of more than understood. Machine learning is most simply 
defined as the use of various statistical techniques that can 
be employed to make predictions and decisions based on 
similarities in what is being analyzed to what has previously 
been observed.” The review gave a nice state-of-the-art over-
view and pointed out aspects of what still needs to be done to 
set free the potential of applying machine learning to physio-
logical data. A key point was that we rarely see true machine 
learning, in the sense that most of the implemented models 
are static models that do not continue to learn from collected 
data. The authors defined this a hybrid format of machine 
learning, because machine learning is used to develop the 
(finally) static model. The authors discussed the role of 
machine learning and also acknowledge other artificial intel-
ligence algorithms such as physiologic modelling. But, no 
matter the algorithm, human clinical knowledge will always 
remain necessary in the care of patients [46]. The authors 
reviewed specific clinical monitoring problems, where 
machine learning may play a role such as identification of 
sepsis, delirium, and ventilator dyssynchrony or reduction 
of false alarms and sedation management. At the time of 
writing the review, none of the reviewed methods had pro-
vided clear indications for a clinical benefit, but this prob-
ably reflects the negligible pool of prospective validation 
studies likely to emerge in coming years. The authors finally 
discussed various perspectives of the future implementa-
tion of machine learning algorithms and what obstacles 
need to be addressed. These include the imperative aspects 
of false alarms, technological development for hospital IT-
infrastructure to support real-time implementation of algo-
rithms, and the need for model explainability for clinicians 
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(as opposed to black-boxes) to understand and perhaps even 
“adhere to” e.g., predictions made by a machine learning 
model. As discussed by the authors, this may require a new 
type of clinician with a strong trans-disciplinary knowledge 
and mindset. The review is highly recommended reading!
In line with the aspects of the review, the editorial by 
Vistisen et al. [45] accompanying the paper by Yoon et al. 
[40] also highlighted the need for sensible methodology 
and clear reporting of studies applying machine learning 
to physiologic data. Yoon et al. [40] developed a model to 
predict tachycardia based on 1-min trending values of vital 
signs such as heart rate, blood pressure, respiratory rate, and 
spectral features of these. Based on 787 episodes of tachy-
cardia (cases) and 705 control periods without tachycardia 
(non-cases), the authors predicted tachycardia with an AUC 
ROC of 0.81 with their developed algorithm. The editorial 
discussed how to identify the data sets for cases and non-
cases, a selection that is fundamentally acausal if the exist-
ence of an event is used to define the data set, i.e. if analyz-
ing only selected temporal windows preceding events and 
non-events, which Yoon et al. [40] did. In turn, one would 
expect a dramatically different performance of such an algo-
rithm, once set free in a prospective validation study, likely 
associated with an unacceptably high false positive rate, i.e. 
false alarms [45]. Also, the handling of correlated features 
is important to consider along with the choice of prediction 
model. Finally, model evaluation is important, not least to 
compare the model performance with that of a simple refer-
ence model, such as carry-forward classification, which in 
this case would be heart rate, since the prediction concerned 
tachycardia (but would be e.g., blood pressure if the predic-
tion was concerning hypotension). Yoon et al. [40] chose 
a sensible modelling approach, where correlated features 
should be handled well. Still, some expectedly highly cor-
related features seemed to remain in the final model, which 
theoretically may be suboptimal, and the authors refrained 
from comparing with a simple carry-forward model.
The study by Donald et al. [41] presented a Bayesian 
artificial neural network approach for predicting hypoten-
sion in neurocritical care patients suffering traumatic brain 
injury. The authors felt that the algorithm worked well, even 
though the AUC ROC was only in the range of 0.7, which is 
not as good as that reported for existing predictive moni-
toring [47]. An important aspect, however, is that Donald 
et al. [41] were working on a more difficult cohort, likely to 
present with severe and/or paroxysmal autonomic problems. 
The way the authors predicted hypotension was also differ-
ent, e.g., predictions were generally made early with respect 
to hypotensive events (15–20 min) and based on other hypo-
tension definitions and therefore difficult to compare with 
previous research [47]. Regarding the aspects suggested to 
be reported for such a study [45], it appeared that no clas-
sification comparison was made with a simple carry-forward 
model, i.e. blood pressure itself. Also, the authors created 
their dataset in the same acausal way described above. Yet, 
the authors were very much aware of the possible problems 
of false positive classification and should be commended for 
taking the first steps in order to improve that possible issue.
Matam et al. [42] described a machine learning based 
framework to predict cardiac arrest in the pediatric ICU. 
The authors presented an extremely well annotated data set, 
where several auditing steps were taken to confirm the cor-
rectness of the labels defining ground truth—cases and non-
cases of cardiac arrest. Also, the authors correctly stratified 
the modelling on age groups because pathophysiology of 
hemodynamic features (such as heart rate) change from new-
borns to teenagers, which the data set spanned. The features 
used for the prediction was derived from normal vital signs, 
i.e. heart rate, respiratory rate, blood pressure, saturation 
(both 125 Hz waveform data and 5 s trending data). The 
machine learning approach was somewhat different from 
the regular understanding of the term machine learning, 
where a training set—features from both cases and non-cases 
– is fed to a learning algorithm that seeks to differentiate 
between the two case groups. In the study, an auto-regressive 
model was developed, in which non-cases were modelled. 
Afterwards, that model was presented with a balanced and 
matched set of 69 cases and 69 non-cases and the algorithm 
predicted cardiac arrest with a AUC ROC of around 0.75 
10 min in advance of events. The peripheral oxygen satura-
tion signal seemed to provide similar classification (AUC ROC 
of 0.77), so the more advanced combination of vital signs 
in this group of patients for this predictive purpose may not 
be very beneficial. This highlights the need for reporting 
comparative classification of simple/existing monitoring 
[45]. After the model development and classification, the 
authors had clinicians to audit the data set to define which 
cardiac arrests were clinically possible to predict and com-
pared their classification with that. They highlighted that 
only few (6%) cardiac arrest events were judged clinically 
predictable, whereas their algorithm predicted 91% of these 
events. This may be on the expense of specificity, and since 
the data selection appeared acausal in this study, false alarms 
may be an issue to handle in a future, prospective validation 
study, which we hope the authors will conduct.
JCMC also published a validation study that reported 
clinical outcome data before and after the implementation of 
the Continuous Monitoring of Event Trajectories (CoMET) 
system (Advanced Medical Predictive Devices, Diagnostics, 
and Displays, Charlottesville, VA, USA) in a surgical ICU 
[43]. The CoMET system visualizes an underlying algo-
rithm’s estimation of cardiorespiratory instability. Rumin-
ski et al. [43] estimated the occurrence of different clinical 
outcomes 7 months before and 7 months after clinical imple-
mentation: septic shock development (sepsis-II definition), 
hemorrhage, respiratory failure, and ICU mortality. The 
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authors showed that the rate ratio (before/after ratio of events 
indexed to patient days in the ICU) of septic shock was sig-
nificantly lower in the “after implementation” period. A total 
of 34 patients developed septic shock in the before period 
and only 17 did so in the after period. In a control cohort 
from a medical ICU, similar changes were not seen. These 
data seem promising, but should still be treated with some 
caution. First, the study is not a randomized controlled trial, 
and before/after studies, particularly those that are retrospec-
tive, hold potential for various types of biases. For instance, 
a randomized controlled trial would always be prospectively 
defined and virtually always be announced in a trial registry 
in advance of the trial, declaring primary and secondary 
outcomes, analysis plans, etc. It would have been a convinc-
ing asset, if this before/after study had been prospectively 
defined. Choices of outcomes and their definitions (e.g., 
choosing to index number of events to length of ICU stay) 
and other aspects, for instance the choice of 7 (and not e.g., 
12) months defining before and after periods would then be 
more clear. Before/after studies also need to evaluate how 
patients were included and excluded. An important aspect of 
the inclusion for the “septic shock analysis” is that approxi-
mately 134 patients out of 840 (16%) were identified with 
shock on ICU admission in the before period. In the after 
period, this figure was around 200 patients out of 907 (22%). 
These (statistically highly significant) disproportions may be 
something to consider as a possible selection bias, because 
these patients were excluded from subsequent analysis and 
could therefore for instance not “develop” a septic shock in 
the analyzed cohorts. Looking at crude absolute number of 
events, a “reduction” of 17 septic shock cases (from 34 to 
17) was observed. However, ICU mortality still “increased” 
with 15 cases (from 55 to 70), which was not explained by 
slightly different cohort sizes, so the point estimate of all-
cause mortality increased – which sure enough could also be 
biased by the different rates of shock-on-admission. While 
definitely applauding the authors for taking the next step of 
validation of machine learning algorithms, firm conclusions 
are inherently difficult to draw from retrospective before/
after studies as compared with more controlled designs.
In the study by Maheshwari et al. [44], the authors seg-
mented a multicentric clinical dataset of 1786 patients hav-
ing colorectal surgery. The segmentation was done with 
topographical data analysis, which can group patients in 
an advanced way based on the various features from the 
dataset, while maintaining a transparent and interpretable 
reporting/visualization of which features drove the segmen-
tation. The segmentation algorithm identified nine distinct 
groups and saw that clinical treatments such as ketorolac use 
and less intra-operative fluid were associated with the best 
clinical outcomes. The association between fluid adminis-
tration and clinical outcome is not new, which the authors 
recognized. The authors also stated that their tool is neither 
meant to establish causality in any way, nor as state-of-the-
art epidemiological tool. The system is a very strong tool 
for providing feedback about clinical practice and its varia-
tion to individual clinicians, clinical teams, and the clinical 
administration. If data and the analysis from such a system 
is interpreted with a clear understanding of what biases may 
impact associations, it would likely be a valuable tool to pro-
vide a foundation for an internal, clinical discussion about 
e.g., adherence to treatment guidelines such as enhanced 
recovery after surgery programs. This is possible given the 
transparent nature of the system and a nicely highlighted 
perspective of the authors.
In summary, machine learning techniques gain wide-
spread interest and utilization. JCMC not only publishes 
but also receives an increasing number of papers applying 
machine learning to hemodynamic and clinical data. The 
field is still new but exciting for authors, editors, and review-
ers and we look very much forward to seeing which impact 
all these efforts provide in future, preferably prospective, 
studies. Studies need sufficient reporting [45] as well as dis-
cussion of various bias types [46], particularly if studies are 
retrospective, which the vast majority of published papers 
still are. Potential biases in the underlying (retrospective) 
data are difficult to identify and evaluate when advanced and 
hard-to-interpret machine learning algorithms are applied 
to them.
8  Technical developments
In an in-silico study, Rinehart et al. [48] evaluated the per-
formance of a closed-loop vasopressor controller during dif-
ferent levels of norepinephrine responsiveness. The authors 
have previously [49] shown acceptable functionality with 
varying degrees of infusion line delay and altered pharma-
cokinetics. A physiologic Monte-Carlo simulation was used 
to simulate 3500 random septic patients with seven differ-
ent levels of norepinephrine response ranging from 0.1 × to 
10 × with 1 × as reference for a usually expected response. 
Additionally, the simulated patients were separated into hav-
ing stable and dynamic sepsis through the application of a 
stable or randomly changing “shock factor” to mimic vaso-
dilation. The performance of the controller for each level 
was evaluated through the median performance error and 
median absolute performance error, wobble analysis, and 
time out of specific target ranges. The median performance 
error was less than 5% and the wobble was below 3% for all 
response levels. The divergence was negative, but decreased 
towards zero at the highest (10x) response level resulting in 
oscillating blood pressure levels. The authors explain this 
phenomenon with the controller not being able to make 
small enough adjustments. In contrast, the time out of target 
range was significantly longer at the lowest norepinephrine 
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response levels of 0.1 × and 0.2 × compared to usual norepi-
nephrine response due to decreased correction speed as the 
controller slowly adjusted infusion rate. Overall the results 
are promising and the authors conclude that the closed-loop 
vasopressor controller remained effective despite different 
norepinephrine response levels. This is an important finding 
and shows that the investigated closed-loop controller is able 
to adjust for unknown physiological variations. Research in 
this field has made great progress in the last years and auto-
mated or semi-automated infusion of vasopressors, fluids 
as well as anesthetics may support our daily work in the 
operating room and ICU in the future.
A nationwide survey was conducted by Scholten et al. 
[50] to investigate the role of ultrasound in the current prac-
tice for the placement of central venous catheters among 
anesthesiologists and intensivists in the Netherlands. All 
Members of the Dutch Society of Anaesthesiology (Ned-
erlandse Vereniging voor Anesthesiologie) and the Dutch 
Society for Intensive Care (Nederlandse Vereniging voor 
Intensive Care) were invited to participate in the survey. The 
survey included questions regarding physician and hospital 
characteristics, the use of ultrasound as well as the NEO 
Five-Factor Inventory-3 (NEO-FFI-3), a questionnaire to 
evaluate personality domains (extraversion, openness to 
experience, agreeableness, and conscientiousness). A total 
of 506 out of 2,291 (22%) participants completed the survey 
and were included in the analysis. Out of these 506 par-
ticipants, 68% reported that ultrasound was used always 
or almost always for the placement of central venous cath-
eters. The authors identified “working in a non-academic 
non-teaching hospital”, “providing cardiac anesthesia”, and 
“more years of physician experience” as factors associated 
with less frequent use of ultrasound guidance after multivar-
iate analysis. The most cited reasons for not using ultrasound 
were the fear for loss of landmark skills (28.6%), a lack of 
ultrasound equipment (22.7%), and no perceived benefit over 
landmark method (20.9%). Two thirds of the study partici-
pants reported that a complication occurred during central 
venous catheter placement in the past year at their depart-
ment. 43% of these complications occurred despite use of 
ultrasound guidance. Only 13% of the participants had never 
experienced a complication during central venous catheter 
placement. The evaluation of the NEO-FFI-3 showed only a 
minor association of neuroticism and extraversion with the 
use of ultrasound guidance suggesting that personality traits 
only play a minor role in the use of ultrasound guidance. The 
authors conclude that providing evidence supporting the use 
of ultrasound might not be sufficient to increase regular use 
of ultrasound guidance for central venous catheter place-
ment and that change in local protocols is necessary and can 
improve patient safety.
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